Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Hepatitis C virus | Hepatitis C virus NS5B RNA-dependent RNA polymerase | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | dihydrofolate reductase-thymidylate synthase | 0.5194 | 0.5295 | 0.5 |
Onchocerca volvulus | 0.1324 | 0.0805 | 0.5 | |
Mycobacterium tuberculosis | Dihydrofolate reductase DfrA (DHFR) (tetrahydrofolate dehydrogenase) | 0.925 | 1 | 1 |
Brugia malayi | thymidylate synthase | 0.1324 | 0.0805 | 0.0805 |
Plasmodium falciparum | bifunctional dihydrofolate reductase-thymidylate synthase | 0.5194 | 0.5295 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.063 | 0 | 0.5 |
Plasmodium vivax | bifunctional dihydrofolate reductase-thymidylate synthase, putative | 0.5194 | 0.5295 | 0.5 |
Echinococcus granulosus | dihydrofolate reductase | 0.925 | 1 | 1 |
Loa Loa (eye worm) | dihydrofolate reductase | 0.925 | 1 | 1 |
Toxoplasma gondii | bifunctional dihydrofolate reductase-thymidylate synthase | 0.5194 | 0.5295 | 0.5 |
Mycobacterium leprae | DIHYDROFOLATE REDUCTASE DFRA (DHFR) (TETRAHYDROFOLATE DEHYDROGENASE) | 0.925 | 1 | 1 |
Schistosoma mansoni | dihydrofolate reductase | 0.925 | 1 | 1 |
Chlamydia trachomatis | dihydrofolate reductase | 0.925 | 1 | 0.5 |
Echinococcus multilocularis | dihydrofolate reductase | 0.925 | 1 | 1 |
Trypanosoma brucei | dihydrofolate reductase-thymidylate synthase | 0.5194 | 0.5295 | 0.5 |
Brugia malayi | Dihydrofolate reductase | 0.925 | 1 | 1 |
Mycobacterium tuberculosis | Probable thymidylate synthase ThyA (ts) (TSASE) | 0.1324 | 0.0805 | 0.0805 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase | 0.5194 | 0.5295 | 1 |
Mycobacterium ulcerans | dihydrofolate reductase DfrA | 0.925 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 0.04 uM | Inhibitory activity against HCV 4a NS5B full length RNA dependent RNA polymerase | ChEMBL. | 16260131 |
IC50 (binding) | = 0.04 uM | Inhibitory activity against HCV 4a NS5B full length RNA dependent RNA polymerase | ChEMBL. | 16260131 |
IC50 (binding) | = 0.15 uM | Inhibitory activity against delta-21 C-terminally truncated HCV 1b (BB7 isolate) RNA dependent RNA polymerase | ChEMBL. | 16260131 |
IC50 (binding) | = 0.15 uM | Inhibitory activity against delta-21 C-terminally truncated HCV 1b (BB7 isolate) RNA dependent RNA polymerase | ChEMBL. | 16260131 |
permeability (ADMET) | > 30 nM/s | Permeability across Caco2 cell membrane | ChEMBL. | 16260131 |
permeability (ADMET) | > 30 nM/s | Permeability across Caco2 cell membrane | ChEMBL. | 16260131 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.